What's so important about conducting research involving third parties?

Area of Science:

• Biomedical Ethics
• Genetic Epidemiology
• Public Health Policy

Background:

• Biomedical research traditionally collects family health history, involving data from individuals not directly participating (third parties).
• A recent federal ruling mandates informed consent from third parties or a waiver, complicating data collection.
• Traditional family medical history questionnaires may no longer meet waiver criteria, posing challenges for research.

Purpose of the Study:

• To address the controversy surrounding informed consent for third-party data in biomedical research.
• To explore the implications of new federal regulations on family health history collection.
• To facilitate discussion and policy development regarding third-party rights in research.

Main Methods:

• A 2-day conference convened international experts in ethics, law, regulation, and science.
• Discussions focused on the necessity of informed consent from third parties for health information.
• Presentations aimed to clarify issues and inform policy recommendations.

Main Results:

• The ruling necessitates informed consent from all third parties or a waiver, impacting standard research practices.
• The application of this ruling challenges the feasibility of traditional family history data collection in genetic studies.
• The conference highlighted the far-reaching implications for research quality and disease etiology studies.

Conclusions:

• The new regulatory landscape significantly alters how family health history can be gathered for research.
• Failure to adapt to informed consent requirements could impede crucial research into human diseases.
• Further policy development is needed to balance research needs with third-party privacy rights.